Cryogatt Systems Limited, world leaders in Cryogenic Radio Frequency
Identification (RFID), are proud to announce that CARE Fertility, the
leading IVF brand in the UK and major international key IVF opinion leaders,
have made an equity investment in Cryogatt. This investment is to solidify
the collaboration between Cryogatt and CARE conducted over the past few
years, regarding the introduction of RFID labelling technology into the IVF
Collaboration to date has focused on RFID technology product development of
sample labelling – with its associated track, trace and electronic assurity
of correct sample identification – on the cold chain, including site to site
shipping. The application of the technology is likely to expand during this
next phase of collaboration.
CARE will be taking up a non-executive Board position with Cryogatt.